Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-08 @ 1:05 AM
Study NCT ID:
NCT02748694
Status:
COMPLETED
Last Update Posted:
2021-03-19
First Post:
2016-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study
Sponsor:
Neurocrine Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-20
First Submit QC Date:
None
Study First Post Date:
2016-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-22
Results First Submit QC Date:
None
Results First Post Date:
2021-03-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-17
Last Update Post Date:
2021-03-19
Last Update Post Date Type:
ACTUAL